¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Çѱ¹À¯¹æ¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 School of Breast Disease : 2021-08-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Çѱ¹À¯¹æ¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 School of Breast Disease : 2021-08-21
±³À°ÀÏÀÚ : 2021-08-21
±³À°Àå¼Ò : ¿Â¶óÀΠ 
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 School of Breast Disease
ÁÖÃÖ±â°ü : Çѱ¹À¯¹æ¾ÏÇÐȸ
´ã´çÀÚ : Á¤Áö¿µ
¿¬¶ôó : 02-3461-6060  
À̸ÞÀÏ : kbcs@kbcs.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ08:30~08:55 Breast imaging: MMG Tomo US  ½ÅÈñÁ¤(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ08:55~09:20 Breast imaging: MRI and Other Breast Imaging Tool  ¼Û¼ºÀº(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ09:20~09:45 Breast pathology: surgical pathology issues of practical importance  À¯ÇѼ®(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ09:45~10:10 Breast cancer staging & biomarker  ÀÌÀº½Å(°í´ë¾È¾Ïº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ10:10~10:35 Management of benign breast disease  È«¼öÁ¤(¾Æ»êÀ¯¿Ü°ú) 
È޽Ġ08-21 ¿Â¶óÀΠ10:35~10:55 È޽Ġ () 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ10:55~11:20 Surgical Consideration for the primary tumor: mastectomy & BCS, oncoplastic procedure  ¹Ú¼º¹Î(ÃæºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ11:20~11:45 Surgical Consideration for the axilla: SLNBx & ALND  ÀÌÇѺ°(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ11:45~12:10 Introduction of endoscopic & robotic breast surgery  ±èÁö¿¹(¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ12:10~12:35 Adjuvant radiation therapy after breast conserving therapy  ±è³ª¸®(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ12:35~13:00 Postmastectomy radiation and RT in metastatic breast cancer  ±è±Ôº¸(ÀÌ´ë¸ñµ¿º´¿ø) 
½Ä»ç 08-21 ¿Â¶óÀΠ13:00~14:00 ½Ä»ç  () 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ14:00~14:30 Adjuvant/neoadjuvant chemotherapy  ÀÌ´ë¿ø(¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ14:30~15:00 Adjuvant/neoadjuvant endocrine therapy  Á¤ÀçÇÐ(À»Áö´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ15:00~15:30 Adjuvant/neoadjuvant targeted therapy  ±è¹Îȯ(¼¼ºê¶õ½ºº´¿ø) 
È޽Ġ08-21 ¿Â¶óÀΠ15:30~15:50 È޽Ġ () 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ15:50~16:20 Emerging therapy for TN breast cancer  ÀÓ½ÂÅÃ(¿øÁÖ¼¼ºê¶õ½ºº´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ16:20~16:50 Metastatic HER2 positive breast cancer  ¼­°æÁø(ºÐ´ç¼­¿ï´ëÇб³º´¿ø) 
±³À°½Ã°£ 08-21 ¿Â¶óÀΠ16:50~17:20 Hormone dependent metastatic breast cancer  À̼öÀÌ(µ¿¾Æ´ëÇб³º´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Çѱ¹À¯¹æ¾ÏÇÐȸ (¿Â¶óÀÎ) 2021 School of Breast Disease : 2021-08-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) ºÎ»ê¼Ò¾Æû¼Ò³â°ú Áöȸ ½ÉÆ÷Áö¾ö : 2021-08-21
´ÙÀ½±Û ´ëÇÑ´ç´¢º´ÇÐȸ (¿Â¶óÀÎ) 8¿ù EGDM (Essential Guideline to Diabetes Management) : 2021-08-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
198 ±¤ÁÖ 2018 Àü³²´ëÇб³º´¿ø ½ÅÀå³»°ú ¿¬¼ö°­Á : 2018-09-02 0 928 2018-07-28
197 ¼­¿ï ´ëÇѺñ¸¸°Ç°­ÇÐȸ 2018 Ãß°èÇмú´ëȸ : 2018-09-02 0 981 2018-07-28
196 ¼­¿ï Á¦3ȸ °æÈñ´ëÇб³º´¿ø ¿°Áõ¼ºÀåÁúȯ¼¾ÅÍ °³¿øÀÇ ¿¬¼ö°­Á -¿°Áõ¼ºÀåÁúȯ Áø·áÀÇ ÃֽŠµ¿Çâ - : 2018-09-02 0 1,508 2018-07-28
195 ´ë±¸ ´ë±¸°¡Å縯´ëÇб³º´¿ø ÀÏÂ÷Áø·á¿¡¼­ ÈçÈ÷ º¸´Â ·ù¸¶Æ¼½ºÁúȯÀÇ °¨º°Áø´Ü ¹× Ä¡·á ¹Ù·Î ¾Ë±â : 2018-09-02 0 939 2018-07-28
194 ¼­¿ï ´ëÇÑÀçÈ°ÀÇÇÐȸ Ã߰迬¼ö°­Á : 2018-09-02 0 392 2018-07-28
193 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾È°úÁúȯÀÇ ÃÖ½ÅÁö°ß : 2018-09-02 0 2,310 2018-07-28
192 ¼­¿ï Á¦21ȸ ¼­¿ï¾Æ»êº´¿ø ³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2018-09-02 0 787 2018-07-28
191 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦21ȸ »ï¼º ºÎºñµ¿ ³»½Ã°æ¼ö¼ú ½ÉÆ÷Áö¾ö : 2018-09-02 0 625 2018-07-28
190 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø SNUH 3A(Anesthesiology Alumni Annual)Update : 2018-09-01 0 541 2018-07-28
189 ¼­¿ï °­ºÏ»ï¼ºº´¿ø ¾È°úÇб³½Ç ½ÉÆ÷Áö¾ö : 2018-09-01 0 666 2018-07-28
188 ºÎ»ê 2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(9¿ù 1ÀÏ) : 2018-09-01 0 571 2018-07-28
187 Á¦ÁÖ ´ëÇÑ°£ÇÐȸ °£Áúȯ ÃֽŠÁö°ß update : 2018-09-01 0 441 2018-07-28
186 ¼­¿ï ´ëÇѺñ´¢±â°úÇÐȸ 2018 KPS-APSU Joint International Symposium : 2018-09-01 0 643 2018-07-28
185 °­¿ø ´ëÇѽŻý¾ÆÇÐȸ Á¦9Â÷ ±³À°¼¼¹Ì³ª ¥± : 2018-09-01 0 391 2018-07-28
184 °æ³² 2018 ºÎ»ê¿ï»ê°æ³² ¼Ò¾Æ½Å°æÁöȸ ½ÉÆ÷Áö¾ö: IMPROVING MANAGEMENT SKILLS IN PEDIATRIC NEUROLOGY : 2018-09-01 0 702 2018-07-28
1391 | 1392 | 1393 | 1394 | 1395 | 1396 | 1397 | 1398 | 1399 | 1400
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷